RARA CRAFT DATABASE for FDA Medical Devices
510(k)K261734

FDA DEVICE FACTS

Klassic Infection Spacer System

Total Joint Orthopedics, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 23, 2026PRODUCT CODEJWH

Indications for use

The Klassic® Knee System is intended for prosthetic replacement in treatment of the following:

• Patient conditions of non-inflammatory degenerative joint disease (NIDJD): avascular necrosis and osteoarthritis

• Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis

• Patients with failed previous surgery where pain, deformity, or dysfunction persists

• Correctable varus-valgus deformity and moderate flexion contracture

• Revision of a previously failed knee arthroplasty

• Patients who require a total knee replacement The Klassic® Knee System is indicated for cemented use only, except for the Klassic Femur with Cobalt 3D®, the Klassic Tibial Baseplate with Ti-Coat® and the Universal® Cone with Ti-Coat, which are indicated for cementless use. The Klassic® Knee System is also indicated for temporary use (maximum 180 days) as an adjunct to total knee replacement (TKR) in patients undergoing a two-stage procedure due to a septic process and where gentamicin is the most appropriate antibiotic based on the susceptibility pattern of the infecting micro-organism(s). The Infection Spacer Stem Dowel, Infection Spacer Femur Adapter and Infection Spacer Femur Adapter, Ti are only indicated for this temporary use. These devices are intended for implantation with FDA cleared gentamicin loaded bone cement following implant removal and radical debridement, and in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach for an infection). For the first stage revision, these devices are not intended for use for more than 180 days, at which time they must be explanted and permanent devices implanted, or another appropriate treatment performed (e.g. resection arthroplasty, fusion, etc.). These devices are only indicated for patients who will consistently use traditional mobility assist devices (e.g. crutches, walkers, canes) throughout the implantation period.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 11, 2026